Research The Renal program is committed to improving the quality of renal care and is actively involved in the research community. Following are some of the studies that were commenced, on-going, or completed in 2015/16. Table 10.1 Summary of Research in Renal Program Name of Study Study Hypothesis/ Objective # of End Lead(s) patients date or enrolled C Dr. S Registry study for ADPKD on Not yet Industry Canadian Medical Soroka, Dr. Jinarc started Assessment of Penelope but to JINARC™ Poyah enroll 50 Medication Amany Aly, A retrospective analysis of 100 2016 CDHA Reconciliation in Holly the impact of medication pharmacy the Clinic Carver, Dr. reconciliation in the Renal research Jo-Anne Clinic to determine the Wilson, patient safety impact of Marsha medication reconciliation. Wood, Dr. Penelope Poyah, Matt Phillips, Cindy Everett, Anne Hiltz CFDI Canadian Dr. M. West Prospective of enzyme 420 Oct 1 Provincial replacement therapy in 2016 Fabry disease Fabry disease Initiative sponsored LAL-CL06 Dr. M. West Study of Sebilipase enzyme 1 2017 Industry replacement therapy in lysosomal lipase deficiency
Research The Renal program is committed to improving the quality of renal care and is actively involved in the research community. Following are some of the studies that were commenced, on-going, or completed in 2015/16. Table 10.1 Summary of Research in Renal Program Name of Study Study Lead(s) Hypothesis/ Objective # of patients enrolled End date or C Canadian Medical Assessment of JINARC™ Dr. S Soroka, Dr. Penelope Poyah Registry study for ADPKD on Jinarc Not yet started but to enroll 50 Industry Medication Reconciliation in the Clinic Amany Aly, Holly Carver, Dr. Jo-Anne Wilson, Marsha Wood, Dr. Penelope Poyah, Matt Phillips, Cindy Everett, Anne Hiltz A retrospective analysis of the impact of medication reconciliation in the Renal Clinic to determine the patient safety impact of medication reconciliation. 100 2016 CDHA pharmacy research CFDI Canadian Fabry disease Initiative Dr. M. West Prospective of enzyme replacement therapy in Fabry disease 420 Oct 1 2016 Provincial sponsored LAL-CL06 Dr. M. West Study of Sebilipase enzyme replacement therapy in lysosomal lipase deficiency 1 2017 Industry
renal-program-annual-report-20152016.docx